World's Best Scientists 2026 revealed!
Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
123
Citations
70416
World Ranking
3295
National Ranking
59

Hideo Baba publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hideo Baba sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 2,112 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hideo Baba D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hideo Baba sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 123 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Hideo Baba is affiliated with Kumamoto University in Japan, specializing in medical research with a focus on oncology and surgery.

Their research contributions span multiple fields and subfields, including:

  • Medicine
  • Oncology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Molecular Biology

Hideo Baba's work concentrates on key topics in cancer research and treatment, such as:

  • Gastric Cancer Management and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Treatments and Studies
  • Esophageal Cancer Research and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis

Frequent publication venues for Hideo Baba include:

  • Annals of Gastroenterological Surgery
  • Annals of Surgical Oncology
  • Journal of Clinical Oncology
  • Cancer Science
  • British Journal of Cancer

Their notable recent papers include:

  • "Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma," 2020, Cancer Science
  • "Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401-MITSUBA)," 2022, Journal of Hepato-Biliary-Pancreatic Sciences
  • "Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance," 2020, Cancer Research
  • "Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination," 2021, Cell Reports
  • "International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1)," 2021, Annals of Gastroenterological Surgery

Hideo Baba has collaborated extensively with other researchers in the field, including frequent co-authors:

  • Yuji Miyamoto
  • Masaaki Iwatsuki
  • Naoya Yoshida
  • Yoshifumi Baba
  • Shiro Iwagami

Best Publications

  • Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    Kohei Shitara;Mustafa Özgüroğlu;Yung-Jue Bang;Maria Di Bartolomeo

  • CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth

    Takatsugu Ishimoto;Osamu Nagano;Toshifumi Yae;Mayumi Tamada

  • CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

    Ryuma Tokunaga;Wu Zhang;Madiha Naseem;Alberto Puccini

  • Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

    Kosuke Mima;Reiko Nishihara;Zhi Rong Qian;Yin Cao

  • Epithelial–mesenchymal transition in cancer development and its clinical significance

    Masaaki Iwatsuki;Koshi Mimori;Takehiko Yokobori;Hideshi Ishi

  • HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3

    Jerzy Roch Nofer;Markus Van Der Giet;Markus Tölle;Iza Wolinska

  • Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

    Hideki Ueno;Tatsuya Ioka;Masafumi Ikeda;Shinichi Ohkawa

  • A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database.

    Hiroya Takeuchi;Hiroaki Miyata;Mitsukazu Gotoh;Yuko Kitagawa

  • High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

    Yousuke Seo;Hideo Baba M.D.;Toshiro Fukuda M.D.;Masaki Takashima M.D.

  • Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma

    Youhei Tanaka;Hidenobu Kamohara;Kouichi Kinoshita;Junji Kurashige

  • Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice

    Paulus Kirchhof;Larissa Fabritz;Melanie Zwiener;Henning Witt

  • A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy.

    Wataru Kimura;Hiroaki Miyata;Mitsukazu Gotoh;Ichiro Hirai

  • Eculizumab for atypical hemolytic-uremic syndrome.

    Jens Nürnberger;Thomas Philipp;Oliver Witzke;Anabelle Opazo Saez

  • Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A

    Rita Holtwick;Martin van Eickels;Boris V. Skryabin;Hideo A. Baba

  • TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

    Takayuki Yoshino;Nobuyuki Mizunuma;Kentaro Yamazaki;Tomohiro Nishina

  • Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

    Klaus Juergen Schmitz;Jeremias Wohlschlaeger;Hauke Lang;Georgios Charalambos Sotiropoulos

  • MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.

    Yukiharu Hiyoshi;Hidenobu Kamohara;Ryuichi Karashima;Nobutaka Sato

  • Sarcopenia Is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer

    Yuji Miyamoto;Yoshifumi Baba;Yasuo Sakamoto;Mayuko Ohuchi

  • Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis

    Kensuke Yamamura;Yoshifumi Baba;Shigeki Nakagawa;Kosuke Mima

  • Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence

    Yoshihiko Maehara;Tatsuo Oshiro;Kazuya Endo;Hideo Baba

Frequent Co-Authors

Yoshihiko Maehara
Yoshihiko Maehara Kyushu University
Keizo Sugimachi
Keizo Sugimachi Kyushu University
Masaki Mori
Masaki Mori Kyushu University
Yasuyuki Yamashita
Yasuyuki Yamashita Kumamoto University
Ajay Goel
Ajay Goel City Of Hope National Medical Center
Kei Muro
Kei Muro National Cancer Research Institute, UK
Kenichi Sugihara
Kenichi Sugihara Tokyo Medical and Dental University
Shoji Natsugoe
Shoji Natsugoe Kagoshima University
René Adam
René Adam University of Paris-Saclay
Yoshihiro Komohara
Yoshihiro Komohara Kumamoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a spectrum of related healthcare degrees and fulfilling career opportunities. With the rise of flexible online programs, aspiring healthcare professionals now have more accessible paths to advance their skills or pivot into new specialties.

For those exploring leadership roles, knowing how to evaluate healthcare administration degree programs is crucial to ensure your chosen program meets industry standards and sets you up for success.

Registered nurses looking to expand their qualifications can opt for online rn-bsn programs without clinicals, offering a flexible way to earn a BSN while balancing work and personal commitments.

If you’re seeking advanced clinical or leadership opportunities, the shortest msn to dnp program allows qualified nurses to efficiently pursue a terminal degree.

Time-conscious professionals may also consider the shortest dnp program, which provides a streamlined route to doctoral-level expertise.

These diverse pathways exemplify the variety of options available, making it possible to tailor your healthcare education and career to fit your individual goals and needs.

Best Scientists Citing Hideo Baba

Trending Scientists

Recently Published Articles